A key drugmaker lobbying group has joined the legal fight against the federal government’s plan to negotiate Medicare drug prices. The Pharmaceutical Research and Manufacturers of America, or PhRMA, is suing over plans laid out in the Inflation Reduction Act to give the federal coverage program more control over its pharmaceutical costs. PhRMA said in a federal court complaint filed Wednesday that the act forces drugmakers to agree to a “government-dictated price” under the threat of a heavy tax.The complaint said Congress delegated too much authority to the U.S. Department of Health and Human Services to set the prices.
